Associations of the CYP3A5*3 and CYP3A4 *1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese-Reference-Cited by-同舟云学术

Associations of the CYP3A5*3 and CYP3A4 *1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese

Published:2016-08-11 Issue:5 Volume:41 Page:552-558
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Chan S. W.¹,Xiao Y.¹,Hu M.¹,Yin O. Q. P.²,Chu T. T. W.¹,Fok B. S. P.¹,Lee V. H. L.²,Tomlinson B.¹

Affiliation:

1. Department of Medicine and Therapeutics; Prince of Wales Hospital; The Chinese University of Hong Kong; NT Hong Kong SAR China

2. School of Pharmacy; The Chinese University of Hong Kong; Hong Kong SAR China

Funder

Research Grants Council, University Grants Committee

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12433/fullpdf

Reference38 articles.

1. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4;Zhou;Curr Drug Metab,2008

2. Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam;Kharasch;Clin Pharmacol Ther,2007

3. Pharmacogenomics of cytochrome P450 3A4: recent progress toward the “missing heritability” problem;Klein;Front Genet,2013

4. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation;Zanger;Pharmacol Ther,2013

5. Significance of the minor cytochrome P450 3A isoforms;Daly;Clin Pharmacokinet,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous Determination of Cortisol and 6β-Hydroxycortisol in Human Plasma by Liquid Chromatography–Tandem Mass Spectrometry;Journal of Chromatographic Science;2022-05-20

2. Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients;Frontiers in Medicine;2021-09-09

3. Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans;Frontiers in Genetics;2020-08-21

4. Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients;The Journal of Clinical Pharmacology;2019-12-09

5. CYP3A4/5 Activity Probed with Testosterone and Midazolam: Correlation between Two Substrates at the Microsomal and Enzyme Levels;Molecular Pharmaceutics;2018-12-05